Retinoid-interferon therapy of solid tumors
نویسندگان
چکیده
منابع مشابه
Current status of therapy of solid tumors: brain tumor therapy.
Treatment of malignant brain tumors with conventional approaches is largely unsuccessful because curative doses generally cannot be delivered without excessive toxicity to normal brain. Radioimmunotherapy is emerging as an attractive alternative for glioma therapy because of the potential for more selectively irradiating tumor cells while sparing normal tissues. Several institutions are engaged...
متن کاملDevelopment of cell-cycle checkpoint therapy for solid tumors.
Cellular proliferation is tightly controlled by several cell-cycle checkpoint proteins. In cancer, the genes encoding these proteins are often disrupted and cause unrestrained cancer growth. The proteins are over-expressed in many malignancies; thus, they are potential targets for anti-cancer therapies. These proteins include cyclin-dependent kinase, checkpoint kinase, WEE1 kinase, aurora kinas...
متن کاملSolid Tumors - role of biological agents in therapy
New tumor-targeted biological approaches to the therapy of childhood solid tumors have the promise to improve the survival of children with advanced or refractory malignancy with less acute and long term toxicity. The challenge that remains is still similar to that with chemotherapy: identifying metabolic and genetic pathways and targets that are sufficiently different or amplified in the malig...
متن کاملOnivyde for the therapy of multiple solid tumors
Drug delivery system based on nanobiotechnology can improve the pharmacokinetics and therapeutic index of chemotherapeutic agents, which has revolutionized tumor therapy. Onivyde, also known as MM-398 or PEP02, is a nanoliposomal formulation of irinotecan which has demonstrated encouraging anticancer activity across a broad range of malignancies, including pancreatic cancer, esophago-gastric ca...
متن کاملClinical application of adoptive T cell therapy in solid tumors
As an emerging therapeutic approach, adoptive T cell therapy shown promise in advanced solid malignancies. The results obtained in patients with metastatic melanoma and kidney cancer are encouraging because of the visible clinical benefits and limited adverse effects. Recently, the genetically-modified T cells expressing specific T cell receptors or chimeric antigen receptors are just now enter...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: International Journal of Cancer
سال: 1997
ISSN: 0020-7136,1097-0215
DOI: 10.1002/(sici)1097-0215(19970207)70:4<481::aid-ijc20>3.0.co;2-h